![Making IT Count - Immunotherapy Education](https://education.aaaai.org/sites/default/files/styles/course_image/public/makingitcount-stacked_course_image_3.png?itok=hIhjJNul)
Virtual Patient: Needs Rapid IT Buildup
This patient simulation involves a 33-year-old female whose allergy symptoms in the spring and fall significantly affect her. She is a busy professional who travels a lot, so she is seeking an immunotherapy treatment option that requires fewer clinic visits than traditional immunotherapy treatment. You will be required to discuss cluster and rush immunotherapy as treatment options, then adjust her treatment as her symptoms change.
Making IT Count is funded through an educational grant from Merck & Co., Inc.
Target Audience
- Allergist/Immunologists
- Fellows-in-Training
- Allied Health providers
Learning Objectives
Upon completion of this activity, participants should be able to:
- Elect the best long-term treatment for this patient’s allergy symptoms
- Discuss risks, benefits, and logistics of cluster/rush buildup schedules
- Be familiar with pre-medication options for cluster/rush buildup schedules
- Treat asthma in a virtual patient receiving immunotherapy and be familiar with the issues involved in administering immunotherapy to an asthmatic
Chris Calabria, MD FAAAAI
Dilley Allergy and Asthma, San Antonio, TX
Relevant Financial Relationships: None
Tolly Goldberg Epstein, MD FAAAAI
University of Cincinnati, Cincinnati, OH
Relevant Financial Relationships: None
CME Committee Reviewers
Stuart L. Abramson, MD FAAAAI
Shannon Medical Center, San Angelo, TX
Relevant Financial Relationships: None
Kim Mudd, RN MSN CCRP
Johns Hopkins University, Baltimore, MD
Relevant Financial Relationships: None
Kristin Sokol, MD
Beth Israel Deaconess Medical Center Division of Allergy and Inflammation
Relevant Financial Relationships: None
Accreditation Statement
The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement
The American Academy of Allergy, Asthma & Immunology designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CE Designation Statement
The American Academy of Allergy, Asthma, & Immunology (AAAAI) is a Provider, approved by the California Board of Registered Nursing, Provider #10704, for up to 0.25 Contact Hours.
Medium and Method of Physician Participation
Follow these steps to complete the activity:
- Register for the activity.
- Review the CME Info and Disclosure information.
- Complete all required components.
- Complete the Commitment to Change form.
- Complete the activity evaluation.
- Claim your credits. Enter only the number of credits earned based on your participation in the activity.
- Print or save your certificate.
AAAAI Privacy Policy
To verify your participation in live educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at cme@aaaai.org.
Release Date
Original release date: August 19, 2016. Reviewed by Christopher Calabria, MD FAAAAI and Tolly Epstein, MD FAAAAI on October 13, 2018. Valid for credit through August 18, 2020.
Questions
Activity-related questions should be directed to cme@aaaai.org.
Available Credit
- 0.25 AttendanceAttendance credit.
- 0.25 CECE credit.
- 0.25 CMECME credit.
Price
Required Hardware/software
One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari. Internet Explorer is not recommended.
Pop-ups must be enabled in order to access all course content. The course will pop-up in a new window.
When you finish the course, you must close the pop-up in order to move forward.